Newsroom

Categories: Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Sygnature Discovery moves US base to Kendall Square

September 12, 2019

Categories: Biomanufacturing, Biotechnology, Research, Healthcare, General Science, Computing & Technology, Drug Discovery & Development, Pharma, Clinical Research & Trials

The increasing importance of failure in supporting modern research

September 11, 2019

Categories: Omics & Genetics, Biotechnology, Diagnostics & Hospital Laboratory, Healthcare, Microbiology & Infection Control, Pharma, Corporate, Finance & Investor, Medical Devices & Technology

GNA Biosolutions closes $13.5M series C financing round backed by a US/EU consortium

August 5, 2019

Categories: Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Sygnature Discovery & RenaSci strengthen in vivo pharmacology service-offering

May 29, 2019

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, Pharma, Clinical Research & Trials

Loop Genomics launches four new Microbiome kits

May 28, 2019

Categories: Biotechnology, Pharma, Corporate, Finance & Investor

NanoFCM opens European office & centre of excellence for scientific application support

April 30, 2019

Categories: Biomanufacturing, Biotechnology, Diagnostics & Hospital Laboratory, Drug Discovery & Development, Pharma, Veterinary

Jackson ImmunoResearch launches secondary antibodies for VHH discovery

April 17, 2019

Categories: Biotechnology, Computing & Technology, Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Sygnature Discovery announces collaboration with software firm SilcsBio

April 17, 2019

Categories: Biotechnology, Drug Discovery & Development, Pharma, Corporate, Finance & Investor

Senior appointments enhance Sygnature Discovery’s DMPK capabilities

March 21, 2019